Press release – For immediate release – 05:45 pm CET
New date for Median Technologies’ webcasts: February 1st, 2024
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announced today that Fredrik Brag, CEO and Founder of Median Technologies, will provide a company update on February 1, 2024:
- Webcast held in English: at 4:30 pm CET / 10:30 am ET: Registration link
- Webcast held in French: at 6:00 pm CET / 12:00 pm ET: Registration link
Webcast replays will be available on Median’s corporate website after the live sessions.
Pioneering innovative imaging solutions and services, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median’s offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis™, an AI/ML tech-based suite of software as medical devices (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit